Syphilis patients may be most affected by penicillin shortage

John Gregory | May 23, 2016 | Health Exec | Policy & Regulations

Pfizer’s “unanticipated manufacturing delay” involving the recommended treatment for syphilis will pose problems for the growing number of patients with the sexually transmitted infection.

For more on the CDC’s efforts to prioritize available penicillin for syphilis patients, click on the link below:

Penicillin Shortage Could Be A Problem For People With Syphilis

John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Cardiovascular Business

Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.

AI in Healthcare

A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business

FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Syphilis patients may be most affected by penicillin shortage

Related Content

Around the web